20210906-招银国际-CMBI_Research_Focus_List__Our_best_high_conviction_ideas_23页_2mb
报告摘要
CMBI Research Focus List Summary
Core Content Overview
The CMBI (China Merchants Bank Investment) Research Focus List outlines the top long and short investment ideas, with a primary emphasis on long-term growth opportunities across various sectors. The list includes a mix of companies in the Auto, Capital Goods, Property, Healthcare, Insurance, and Internet sectors. The summary below highlights the key companies, their ratings, target prices, and the main investment rationale.
Main Investment Ideas (Long)
| Company | Ticker | Sector | Rating | Target Price (LC) | Upside % | P/E (FY21E) | P/B (FY22E) | ROE (FY21E) | Yield (FY21E) | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|
| BYD – H | 1211 HK | Auto | BUY | HK$405 | 55% | 84.6 | 54.1 | 8.8 | 11.3% | Jack Bai/ Robin Xiao |
| Zhejiang Dingli | 603338 CH | Capital Goods | BUY | RMB87.0 | 19% | 37.8 | 28.5 | 7.9 | 23.0% | Wayne Fung |
| SANY International | 631 HK | Capital Goods | BUY | HK$14.3 | 40% | 20.4 | 16.9 | 3.1 | 16.1% | Wayne Fung |
| ZTO Express | 2057 HK | Express Delivery | BUY | HK$306 | 26% | 33.3 | 25.2 | 3.0 | 9.3% | Wayne Fung |
| Li Ning | 2331 HK | Consumer Disc. | BUY | HK$102.84 | 2% | 60.1 | 49.1 | 17.6 | 30.0% | Walter Woo |
| Prada | 1913 HK | Consumer Disc. | BUY | HK$68.09 | 48% | 53.1 | 38.8 | 4.4 | 8.6% | Walter Woo |
| Innovent Biologics | 1801 HK | Healthcare | BUY | HK$116.89 | 76% | NA | NA | NA | -20.0% | Jill Wu/ Sam Hu |
| China Pacific Insurance | 2601 HK | Insurance | BUY | HK$35.96 | 46% | NA | NA | 0.8 | 12.4% | Gigi Chen |
| CR Land | 1109 HK | Property | BUY | HK$44.8 | 51% | 4.8 | 4.4 | 1.1 | 14.6% | Walter Woo |
| CG Services | 6098 HK | Property | BUY | HK$91.2 | 46% | 30.0 | 21.4 | 25.8 | 0.7% | Wayne Fung |
| China Hongqiao | 1378 HK | Materials | BUY | HK$15.0 | 48% | 4.4 | 4.2 | 0.7 | 22.2% | Wayne Fung |
| BYDE | 285 HK | Technology | BUY | HK$49.5 | 41% | 16.9 | 11.8 | 3.8 | 15.5% | Wayne Fung |
| Willsemi | 603501 CH | Technology | BUY | HK$370.8 | 55% | 46.0 | 34.3 | 13.4 | 28.5% | Lily Yang/ Alex Ng |
| Hikvision | 002415 CH | Software & IT services | BUY | HK$80.0 | 55% | 28.2 | 23.1 | 7.5 | 29.0% | Lily Yang/ Alex Ng |
Key Points and Rationale
- BYD – H: Strong auto sales rebound, with NEV sales at 56.7%. The DM-I series is expected to drive growth. Current valuation is low compared to peers, offering upside potential.
- Zhejiang Dingli: AWP market is entering structural growth. Upgraded to BUY due to potential margin stabilization and growth from major customer Far East Horizon.
- SANY International: Intelligent products and robotic business are key growth drivers. Forward-looking valuation based on 23x P/E.
- ZTO Express: Government intervention is expected to end the cut-throat price war, leading to improved profitability. Current valuation is at historical peak.
- Li Ning: Benefiting from domestic fashion trend. Strong momentum in 2H21, with improved margins and operational efficiency. Trading at 49x P/E.
- Prada: Turnaround confirmed with strong 1H21 results. EBIT margin expected to recover to 15%+ by FY23E. Target price based on 55x P/E.
- Innovent Biologics: Leading in biopharma innovation with a comprehensive pipeline. Target price based on DCF model with 15-year terminal growth.
- China Pacific Insurance: Better-than-peers new business momentum in 1H21. Focus on productivity and technology innovation.
- CR Land: Strong growth in property market with focus on P/E and P/B metrics. Target price based on 50x P/E.
- CG Services: Strong growth in property and materials. Valuation based on 45x P/E.
- China Hongqiao: High P/E and P/B, with strong growth in materials sector.
- BYDE: Technology growth driven by strategic trends. Valuation based on 46x P/E.
- Willsemi: Strong growth in CIS business, with recent correction seen as an opportunity. Target price based on 46x P/E.
Recent Additions and Deletions
Additions:
- Zhejiang Dingli: Upgraded to BUY due to AWP growth and margin stabilization.
- ZTO Express: Added as the government's intervention is expected to end price wars.
- Willsemi: Added due to strong CIS growth and strategic opportunities.
Deletions:
- Zhejiang Jingsheng: Removed as near-term positives were already priced in.
- WH: Removed due to lack of catalysts.
- Hope Education: Removed due to lack of catalysts.
- ZTE: Removed due to uncertainty around 5G deployment.
Performance of Recommendations
- The 17 long ideas in the last report outperformed the MSCI China index by 0.8ppt, delivering a 1.7% return (vs 0.9% for the benchmark).
- Li Ning, CR Land, and Zhejiang Jingsheng were top performers, with returns of 15% or more.
- 10 out of 17 long ideas outperformed the benchmark.
Valuation and Growth Drivers
- Companies are evaluated based on P/E, P/B, and ROE metrics.
- Target prices are based on projected earnings growth and market trends.
- Catalysts include product launches, market share gains, M&A opportunities, and policy changes.
Conclusion
CMBI's research highlights a diverse range of long-term investment opportunities across multiple sectors. The focus is on companies with strong growth potential, favorable valuations, and clear catalysts for future performance. The list reflects a strategic approach to investing in high conviction ideas with sustainable growth trajectories.
试读结束,高清完整版pdf/doc/ppt,请点下载